(June 25, 2020, 1:31 PM EDT) -- BOSTON — The United States on June 24 filed a false claims and kickback civil complaint alleging that Regeneron Pharmaceuticals Inc. funneled “tens of millions of dollars” into a patient-assistance charity so patients could avoid paying a required co-pay for the expensive macular degeneration drug Eylea (United States v. Regeneron Pharmaceuticals, Inc., No. 20-11217, D. Mass.)....